182 related articles for article (PubMed ID: 33099073)
1. Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
Bonnaire A; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115225. PubMed ID: 33099073
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired methicillin-resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance.
Donaldson AD; Chan RC; Gosbell IB
Med J Aust; 2006 Feb; 184(4):196. PubMed ID: 16489910
[No Abstract] [Full Text] [Related]
3. Optimizing combination rifampin therapy for staphylococcal osteoarticular infections.
Coiffier G; Albert JD; Arvieux C; Guggenbuhl P
Joint Bone Spine; 2013 Jan; 80(1):11-7. PubMed ID: 23332140
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.
Valour F; Karsenty J; Bouaziz A; Ader F; Tod M; Lustig S; Laurent F; Ecochard R; Chidiac C; Ferry T;
Antimicrob Agents Chemother; 2014; 58(2):746-55. PubMed ID: 24247130
[TBL] [Abstract][Full Text] [Related]
5. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
O'Reilly T; Kunz S; Sande E; Zak O; Sande MA; Täuber MG
Antimicrob Agents Chemother; 1992 Dec; 36(12):2693-7. PubMed ID: 1336342
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
[TBL] [Abstract][Full Text] [Related]
7. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
Adhikari RP; Shrestha S; Barakoti A; Amatya R
BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
[TBL] [Abstract][Full Text] [Related]
8. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.
Pääkkönen M; Kallio PE; Kallio MJ; Peltola H
Pediatr Infect Dis J; 2012 May; 31(5):436-8. PubMed ID: 22189524
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
10. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
Levin TP; Suh B; Axelrod P; Truant AL; Fekete T
Antimicrob Agents Chemother; 2005 Mar; 49(3):1222-4. PubMed ID: 15728934
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of MRSA infections].
Borde JP; Kern WV
Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
[No Abstract] [Full Text] [Related]
12. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
13. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
[TBL] [Abstract][Full Text] [Related]
14. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.
Siberry GK; Tekle T; Carroll K; Dick J
Clin Infect Dis; 2003 Nov; 37(9):1257-60. PubMed ID: 14557972
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.
Frank AL; Marcinak JF; Mangat PD; Tjhio JT; Kelkar S; Schreckenberger PC; Quinn JP
Pediatr Infect Dis J; 2002 Jun; 21(6):530-4. PubMed ID: 12182377
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
Norden CW; Shinners E; Niederriter K
J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
[TBL] [Abstract][Full Text] [Related]
17. Simplifying the treatment of acute bacterial bone and joint infections in children.
Pääkkönen M; Peltola H
Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1125-31. PubMed ID: 22114963
[TBL] [Abstract][Full Text] [Related]
18. Monomicrobial bone and joint infection due to Corynebacterium striatum: literature review and amoxicillin-rifampin combination as treatment perspective.
Noussair L; Salomon E; El Sayed F; Duran C; Bouchand F; Roux AL; Gaillard JL; Bauer T; Rottman M; Dinh A
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1269-1278. PubMed ID: 30903537
[TBL] [Abstract][Full Text] [Related]
19. Fusidic acid in bone and joint infections.
Atkins B; Gottlieb T
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
[TBL] [Abstract][Full Text] [Related]
20. Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India.
Pal N; Sharma B; Sharma R; Vyas L
J Postgrad Med; 2010; 56(3):182-5. PubMed ID: 20739762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
